Ophthalmology, Retina Specialist · Palm Springs, FL
NPI
1699866301
Since 2006
Specialty
Ophthalmology, Retina Specialist
Code 207WX0107X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
2889 10th Ave N Ste 306
Palm Springs, FL, 33461
Phone (561) 964-0707
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
403 services
Medicare patients, 2024
91
Average age 73
Drug cost, 2024
$1.1M
2,147 prescriptions
Company payments, 2025
$159
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel E Goldberg was code 92134 (computerized ophthalmic imaging), 80 times for 57 patients. In total Daniel E Goldberg billed 403 services in 20 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92134 Computerized Ophthalmic Imaging | Office | 80 | 57 | $29.67 | $2,374 |
| 92014 Ophthalmological E&M | Office | 56 | 45 | $89.53 | $5,013 |
| 92201 Ophthalmological E&M | Office | 38 | 35 | $18.28 | $695 |
| 67028 Intravitreal Injection | Office | 29 | 14 | $85.27 | $2,473 |
| 99213 Office E&M - Established | Office | 25 | 24 | $61.93 | $1,548 |
| 99212 Office E&M - Established | Office | 20 | 18 | $29.48 | $590 |
| 92004 Ophthalmological E&M | Office | 16 | 16 | $97.43 | $1,559 |
| 99214 Office E&M - Established | Office | 14 | 14 | $80.96 | $1,133 |
By year: 2022 $28K for 412 services; 2023 $50K for 775 services; 2024 $25K for 403 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel E Goldberg prescribed most often to Medicare patients was Diclofenac Sodium, with 429 prescriptions and refills. In total Daniel E Goldberg wrote 2,147 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 429 | 497 | 191 | $4,882 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 258 | 514 | 111 | $4,445 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 238 | 246 | 140 | $2,959 |
| Ofloxacin Generic | 117 | 125 | 76 | $1,569 |
| Eylea Hd Aflibercept | 102 | 130 | 33 | $346K |
| Latanoprost Generic | 102 | 154 | 33 | $735 |
| Eylea Aflibercept | 93 | 96 | 42 | $213K |
| Prednisolone Acetate Generic | 91 | 108 | 50 | $3,579 |
| Vabysmo Faricimab-Svoa | 89 | 95 | 29 | $250K |
| Atropine Sulfate Generic | 88 | 95 | 37 | $3,419 |
| Brimonidine Tartrate Generic | 86 | 114 | 30 | $1,368 |
| Avastin Bevacizumab | 66 | 66 | 26 | $60K |
| Ketorolac Tromethamine Generic | 55 | 71 | 23 | $1,059 |
| Restasis Cyclosporine | 37 | 37 | 22 | $21K |
| Timolol Maleate Generic | 37 | 56 | Under 11 | $337 |
Brand drugs: 670 claims; generic drugs: 1,477 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel E Goldberg $159 ($159 in general payments such as food, travel and fees) from 6 companies. The largest payer was Astellas Pharma US Inc with $32.7.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.